Rare diseases
Investigational molecules
Locations
94 Avenue Ledru Rollin, 75011 Paris, France
Enterome’s clinical research includes metastatic colorectal carcinoma, with attention to patients who have unresectable and previously treated disease. The work centers on cancer immunotherapy approaches in a heavily pretreated solid tumor setting.
The sponsor’s activity in this area reflects interest in treatment-resistant gastrointestinal malignancies and combinations involving immune checkpoint inhibition and anti-angiogenic therapy.
Enterome runs clinical trials in conditions such as Non-Hodgkin's lymphoma, Colorectal cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of EO2463, Lenalidomide, and Rituximab for Patients with Indolent Non-Hodgkin's Lymphoma
FranceStudy on EO4010 Vaccine with Nivolumab and Bevacizumab for Patients with Metastatic Colorectal Cancer Who Have Already Received Treatment
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
